No Data
HHS Panel to Vote in Nov. on DMD Screening for Newborns
Capricor Therapeutics to Present Exosome Platform Updates at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
-Preclinical findings show exosome-based therapeutic approach for the treatment of arginase-1 deficiency (ARG1-D)- -Presentation to be featured in an oral session being held on May 9, 2024- SAN DIEGO, May 09, 2024
Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare dise
Boy Given Pfizer Experimental Duchenne Muscular Dystrophy Therapy Dies
Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13
Capricor Therapeutics Updates on Duchenne Treatment Progress
TrytosaveabitOP : Capricor Therapeutics Inc: Granted Subsequent Type-B Clinical Meeting With FDA in Q2 to Continue to Discuss Pathway to Bla